These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33378085)

  • 1. Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy.
    Carlberg VM; Davies OMT; Brandling-Bennett HA; Leary SES; Huang JT; Coughlin CC; Gupta D
    Pediatr Dermatol; 2021 Jan; 38(1):18-30. PubMed ID: 33378085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis.
    Belum VR; Washington C; Pratilas CA; Sibaud V; Boralevi F; Lacouture ME
    Pediatr Blood Cancer; 2015 May; 62(5):798-806. PubMed ID: 25683226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic.
    Rosen AC; Case EC; Dusza SW; Balagula Y; Gordon J; West DP; Lacouture ME
    Am J Clin Dermatol; 2013 Aug; 14(4):327-33. PubMed ID: 23625802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review.
    Liu LY; Teng JMC; Spunt SL; Strelo JL; Kwong BY; Zaba LC
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29346. PubMed ID: 34569142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program.
    Drilon A; Eaton AA; Schindler K; Gounder MM; Spriggs DR; Harris P; Ivy SP; Iasonos A; Lacouture ME; Hyman DM
    Cancer; 2016 Apr; 122(8):1228-37. PubMed ID: 26916138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane.
    Macdonald JB; Macdonald B; Golitz LE; LoRusso P; Sekulic A
    J Am Acad Dermatol; 2015 Feb; 72(2):203-18; quiz 219-20. PubMed ID: 25592338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dermatologic adverse events of the new targeted anticancer therapies used in oncodermatology].
    Sibaud V; Delord JP; Chevreau C; Gangloff D; Garrido-Stowhas I
    Ann Chir Plast Esthet; 2012 Apr; 57(2):106-13. PubMed ID: 22425393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.
    Lacouture M; Sibaud V
    Am J Clin Dermatol; 2018 Nov; 19(Suppl 1):31-39. PubMed ID: 30374901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Adverse Events of Targeted Therapies for Hematolymphoid Malignancies.
    Ransohoff JD; Kwong BY
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):834-851. PubMed ID: 28918995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study.
    Barrios DM; Phillips GS; Freites-Martinez A; Hsu M; Ciccolini K; Skripnik Lucas A; Marchetti MA; Rossi AM; Lee EH; Deng L; Markova A; Myskowski PL; Lacouture ME
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1340-1347. PubMed ID: 31856311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatologic adverse events to targeted therapies in lower GI cancers: clinical presentation and management.
    Belum VR; Cercek A; Sanz-Motilva V; Lacouture ME
    Curr Treat Options Oncol; 2013 Sep; 14(3):389-404. PubMed ID: 23996476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the Literature.
    Belzer A; Pach JJ; Valido K; Leventhal JS
    Am J Clin Dermatol; 2024 May; 25(3):435-445. PubMed ID: 38366030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study.
    Song H; Zhong CS; Kieran MW; Chi SN; Wright KD; Huang JT
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27682. PubMed ID: 30821092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal vestibulitis due to targeted therapies in cancer patients.
    Ruiz JN; Belum VR; Boers-Doets CB; Kamboj M; Babady NE; Tang YW; Valdez TA; Lacouture ME
    Support Care Cancer; 2015 Aug; 23(8):2391-8. PubMed ID: 25876156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.
    Cury-Martins J; Eris APM; Abdalla CMZ; Silva GB; Moura VPT; Sanches JA
    An Bras Dermatol; 2020; 95(2):221-237. PubMed ID: 32165025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy.
    Deutsch A; Leboeuf NR; Lacouture ME; McLellan BN
    Am Soc Clin Oncol Educ Book; 2020 May; 40():485-500. PubMed ID: 32421446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma.
    Dika E; Patrizi A; Ribero S; Fanti PA; Starace M; Melotti B; Sperandi F; Piraccini BM
    Eur J Dermatol; 2016 Jun; 26(3):232-9. PubMed ID: 27019511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer therapies associated with secondary cutaneous malignancies: A review of the literature.
    Deutsch A; Balagula Y; McLellan BN
    J Am Acad Dermatol; 2020 Nov; 83(5):1425-1433. PubMed ID: 32334055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-rash dermatologic adverse events related to targeted therapies.
    Bryce J; Boers-Doets CB
    Semin Oncol Nurs; 2014 Aug; 30(3):155-68. PubMed ID: 25085027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors.
    Peng Y; Li Q; Zhang J; Shen W; Zhang X; Sun C; Cui H
    Biosci Trends; 2019 Jan; 12(6):537-552. PubMed ID: 30555112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.